335 related articles for article (PubMed ID: 23329365)
1. Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
Tanaka S; Miyanishi K; Kobune M; Kawano Y; Hoki T; Kubo T; Hayashi T; Sato T; Sato Y; Takimoto R; Kato J
J Gastroenterol; 2013 Nov; 48(11):1249-58. PubMed ID: 23329365
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
3. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
4. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.
Tanaka H; Fujita N; Sugimoto R; Urawa N; Horiike S; Kobayashi Y; Iwasa M; Ma N; Kawanishi S; Watanabe S; Kaito M; Takei Y
Br J Cancer; 2008 Feb; 98(3):580-6. PubMed ID: 18231107
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
[TBL] [Abstract][Full Text] [Related]
6. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Yamada T; Sakaguchi H; Nakatani K; Wakasa K
J Hepatol; 2002 Jul; 37(1):56-62. PubMed ID: 12076862
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.
Clarke JD; Novak P; Lake AD; Shipkova P; Aranibar N; Robertson D; Severson PL; Reily MD; Futscher BW; Lehman-McKeeman LD; Cherrington NJ
Dig Dis Sci; 2014 Feb; 59(2):365-74. PubMed ID: 24048683
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma.
Yugawa K; Itoh S; Yoshizumi T; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Pathol Int; 2020 Aug; 70(8):533-541. PubMed ID: 32419286
[TBL] [Abstract][Full Text] [Related]
9. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
Tokushige K; Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Shiratori K
J Gastroenterol; 2010 Sep; 45(9):960-7. PubMed ID: 20376504
[TBL] [Abstract][Full Text] [Related]
11. [The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis].
Jiang Y; Han T; Zhang ZG; Lu SQ; Mi YQ; Xu L; Qi FX; Zhang Y; Song GD
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):34-38. PubMed ID: 28056321
[No Abstract] [Full Text] [Related]
12. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.
Cardin R; Piciocchi M; Sinigaglia A; Lavezzo E; Bortolami M; Kotsafti A; Cillo U; Zanus G; Mescoli C; Rugge M; Farinati F
BMC Cancer; 2012 May; 12():177. PubMed ID: 22587342
[TBL] [Abstract][Full Text] [Related]
13. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
14. Levels of the oxidative stress marker γ-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease.
Irie M; Sohda T; Iwata K; Kunimoto H; Fukunaga A; Kuno S; Yotsumoto K; Sakurai K; Iwashita H; Hirano G; Ueda SI; Yokoyama K; Morihara D; Nishizawa S; Anan A; Takeyama Y; Sakamoto M; Shakado S; Sakisaka S
J Int Med Res; 2012; 40(3):924-33. PubMed ID: 22906265
[TBL] [Abstract][Full Text] [Related]
15. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
[TBL] [Abstract][Full Text] [Related]
16. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.
Kawada N; Imanaka K; Kawaguchi T; Tamai C; Ishihara R; Matsunaga T; Gotoh K; Yamada T; Tomita Y
J Gastroenterol; 2009; 44(12):1190-4. PubMed ID: 19672551
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years].
Tsutsumi K; Nakayama H; Sakai Y; Kojima Y; Dairaku N; Ojima T; Kusano M; Ikeya S; Sugai Y; Hiwatashi N
Nihon Shokakibyo Gakkai Zasshi; 2007 May; 104(5):690-7. PubMed ID: 17485950
[TBL] [Abstract][Full Text] [Related]
20. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
